ATEC · Alphatec Holdings, Inc.
Market Cap
$1.46B
Shares
154.45M
ATEC metrics
73 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$9.45
Market cap
$1.46B
Price action
19 metricsPrice change (1W)
+0.1%
Price change (30D)
-0.4%
Price change (3M)
+18.1%
Price change (6M)
-22.7%
Price change (YTD)
-55.1%
Price change (1Y)
-42.9%
Trailing year
Price change (5Y)
-37.5%
52-week high
$22.68
52-week low
$6.99
Change from 52-week high
-58.3%
Change from 52-week low
+35.2%
Annualized volatility
65.6%
Beta
0.8
RSI (14D)
52.0
Price vs SMA 50
+2.0%
Price vs SMA 200
-24.7%
Avg volume (3M)
2.45M
Relative volume
0.6
Average dollar volume
$22.18M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
154.45M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.4×
reciprocal yield 42.5%
EV / EBITDA
69.2×
reciprocal yield 1.4%
EV / EBIT
—
P / sales
1.8×
reciprocal yield 55.8%
P / book
—
FCF yield
0.2%
TTM · current market cap
Buyback yield
—
P / FCF
632.7
reciprocal yield 0.2%
P / operating cash flow
25.8
reciprocal yield 3.9%
Earnings yield
-7.5%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.4×
reciprocal yield 29.6%
EV / revenue historical average (5Y)
3.9×
reciprocal yield 25.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-04
Profitability
9 metricsGross margin
70.8%
Operating margin
-6.0%
Trailing 12 months
Net margin
-13.5%
Gross profit (TTM)
$577.37M
Operating profit (TTM)
−$49.24M
Net income (TTM)
−$109.99M
Trailing 12 months
Diluted EPS (TTM)
$-0.72
FCF margin
0.3%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+15.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$815.05M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.4%
Year over year · more shares
Revenue CAGR (3Y)
+29.6%
Revenue CAGR (5Y)
+39.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-13.9%
Debt / equity
—
Current ratio
1.9
EBITDA (TTM)
$27.68M
Free cash flow (TTM)
$2.31M
Quick ratio
1.1
Interest coverage
-1.0
Net debt / EBITDA
16.5
Return on invested capital
—
Trailing 12 months
Net cash
−$457.09M
Latest balance sheet
Cash & equivalents
$118.66M
Total assets
$791.03M
Total debt
$575.75M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$56.52M
Capital expenditures (TTM)
$54.22M
R&D (TTM)
$77.14M
SG&A (TTM)
$524.06M
Stock compensation (TTM)
$77.58M
R&D / revenue
9.5%
Stock compensation / revenue
9.5%
Ownership (13F)
3 metrics13F filers
268
13F filer change QoQ
-18
Institutional ownership
76.4%
Short interest
3 metricsShort interest
8.8%
Latest settlement · 4.8 days to cover
Days to cover
4.8d
Short-squeeze score
60 / 100
Insider activity
2 metricsNet insider buying (90D)
−$127,282
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1350653
CUSIP
02081G201
13F (30d)
167 filings
167 filers
Visit website
Investor relations